Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00443196
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2006-06-14
Brief Title:
Testing Drug Sensitivity of Ovarian Fallopian and Primary Peritoneal Adenocarcinomas
Sponsor:
Pierian Biosciences
Organization:
Pierian Biosciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adenocarcinoma |
| Ovarian Neoplasms |
| Fallopian Tube Neoplasms |
| Peritoneal Neoplasms |
Keywords:
| Name | View |
|---|---|
| Chemosensitivity | View |
| Ovarian Cancer | View |
| Chemotherapy | View |
| Fallopian Adenocarcinoma | View |
| Peritoneal Adenocarcinoma | View |
| Patients with pathological diagnoses of ovarian fallopian and primary peritoneal adenocarcinomas | View |
| Patients with de novo malignancies and no previous chemotherapy | View |
| Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols | View |